Is Optimizely HIPAA Compliant?

Every A/B test starts the same way: a snippet of JavaScript loads in the visitor's browser, reads the page, decides which variant to show, and reports the result back to a server. That sequence feels harmless when you are testing button colors on a retail site. On a healthcare website where the page URL contains a condition name, the form captures symptoms, and the conversion event is "appointment booked," that same sequence becomes a protected health information pipeline that most compliance teams never authorized.

Optimizely is one of the most established experimentation platforms on the market. It powers tests for thousands of organizations across industries. But running Optimizely on a healthcare website introduces architectural questions that do not have simple answers, and the consequences of getting them wrong have become very expensive.

How Optimizely's Experimentation Engine Handles Data

Optimizely offers two distinct experimentation products, and the compliance implications differ substantially between them.

Optimizely Web Experimentation is the client-side product. When you install it, a JavaScript snippet loads on every page where experiments may run. That snippet communicates with Optimizely's servers to retrieve experiment configurations, then modifies the DOM in the visitor's browser to render the assigned variant. As the visitor interacts with the page, the snippet tracks behavioral events (clicks, form submissions, page views, scroll depth) and sends that data to Optimizely's infrastructure for analysis.

On a healthcare site, this means Optimizely's client-side code observes which health condition pages a visitor views, what content variations they engage with, how they interact with appointment scheduling forms, and whether they convert. The data that flows to Optimizely's servers can include page URLs with condition names (e.g., /services/cardiology/heart-failure-treatment), experiment variant assignments tied to health topics, and behavioral signals on pages that contain clinical information.

Optimizely Feature Experimentation (formerly Full Stack) operates differently. This server-side product evaluates feature flags and experiment assignments on your server before the page reaches the visitor's browser. The visitor's browser never communicates directly with Optimizely for experiment decisions. Data about experiment results can be sent to Optimizely from your server, giving you control over what information leaves your infrastructure.

This distinction matters enormously. The compliance risk profile of a client-side JavaScript snippet that freely observes and reports healthcare page interactions is fundamentally different from a server-side SDK where you control every data point that leaves your environment.

The BAA Question for Healthcare Organizations

Optimizely does not typically sign Business Associate Agreements for its Web Experimentation product. For healthcare organizations subject to HIPAA, this is the threshold question. Without a BAA, Optimizely is not accepting liability as a Business Associate, and any protected health information that its client-side JavaScript captures and transmits represents an ungoverned data flow.

A BAA is not a formality. It is the legal mechanism by which a vendor acknowledges that it will handle PHI according to HIPAA requirements. It covers data collection, processing, storage, and transmission. When a tool operates without a BAA on a healthcare site, every piece of data it touches exists outside your compliance framework.

The server-side Feature Experimentation product has different considerations. Because you control the data pipeline on your server, you decide what information (if any) gets sent to Optimizely. This does not eliminate the need for a BAA if PHI is involved, but it changes the nature of the exposure. You can architect the integration so that no PHI reaches Optimizely's servers, using anonymized experiment identifiers and stripping health context before transmitting results.

The critical takeaway: the product you choose and how you configure it determines your risk. The Web Experimentation product, by design, sees what your visitors see. The Feature Experimentation product only sees what you explicitly send it.

What $193 Million in Settlements Reveals About Client-Side Risk

The enforcement pattern across healthcare tracking cases is remarkably consistent. Organizations installed standard marketing and optimization tools on patient-facing websites. Those tools operated client-side, collecting and transmitting data through visitors' browsers to third-party servers. Nobody reviewed whether the data flowing to those servers contained PHI. Years later, the exposure surfaced.

Kaiser Permanente's case is the most instructive. From 2017 to 2024, Kaiser's websites, patient portals, and mobile apps used third-party tracking code that transmitted health information to Google, Microsoft, Meta, and X without member consent. The breach affected 13.4 million members and resulted in a $47.5 million class action settlement. The tracking code was not installed maliciously. It was standard marketing technology, doing exactly what it was designed to do: observe user behavior and report it to third-party servers.

Advocate Aurora Health followed the same trajectory. The system installed Meta Pixel and Google Analytics on its website, app, and patient portal to "better understand patient needs." That well-intentioned decision exposed approximately 3 million patients' data and produced a $12.25 million settlement.

The common thread in every case is architecture: client-side code running in the browser, capturing data that includes health context, and transmitting it to servers where no BAA governs its handling. This is precisely how Optimizely Web Experimentation operates. The experimentation use case does not change the underlying data flow pattern.

Client-Side vs. Server-Side: Why Architecture Decides Compliance

The difference between client-side and server-side experimentation is not a technical preference. It is the architectural divide that separates every enforcement case from every organization that avoided one.

Client-side experimentation tools load JavaScript in the visitor's browser. That JavaScript has access to the full page context: URLs, form fields, page content, user interactions. It sends data to the vendor's servers through the browser, an environment you do not fully control. Browser extensions, other scripts, and network conditions can all influence what data gets transmitted and to whom.

Server-side experimentation evaluates variants on your infrastructure. The experiment decision happens before the page reaches the browser. Your server communicates with the experimentation platform's SDK locally, assigns a variant, renders the appropriate content, and serves it to the visitor. The visitor's browser never knows an experiment is running. No third-party JavaScript loads. No behavioral data flows to an external server through the browser.

For healthcare organizations, this means server-side experimentation can be architected so that PHI never leaves your controlled environment. You can run A/B tests on appointment scheduling flows, service line pages, and patient education content without any third-party code observing what your patients do. Client-side tools, by contrast, require you to trust that the vendor's JavaScript will not capture anything sensitive. Given that the JavaScript's purpose is to observe and report user behavior, that trust is difficult to justify under HIPAA.

Building an Experimentation Stack That Meets the Healthcare Bar

If your organization needs to run experiments on patient-facing web properties, the compliance requirements extend beyond choosing the right product. Here is what a healthcare-grade experimentation setup requires.

A BAA covering the full experimentation data pipeline. If any data from your experiments could contain or be combined with PHI, the vendor processing that data must sign a BAA. This BAA should not carve out "marketing data" or "experimentation data" as exceptions. It should cover every data type the tool processes in connection with your account.

Server-side experiment delivery. Variant assignment and rendering should happen on your server. The visitor's browser should receive the final page content without any communication to the experimentation vendor. This eliminates the class of risk that underlies every major healthcare tracking settlement.

SOC 2 Type II certification across all five trust criteria. Security, Availability, Processing Integrity, Confidentiality, and Privacy, verified by independent auditors over a sustained review period. Most vendors certify only Security (one of five). For healthcare data, the other four criteria matter just as much.

Consent-gated data flows verified server-side. Experiment data should not flow to any destination until consent has been confirmed on the server. A JavaScript consent check can fail to load, be blocked by an ad blocker, or execute after the experimentation script has already fired. Server-side consent gating ensures data physically does not move until consent is confirmed.

Continuous visibility into your site's tracking surface. Installing a compliant experimentation tool does not make your website compliant. Marketing teams add scripts. CMS plugins load third-party resources. Tag managers inject code that loads additional code. Your site's tracking surface changes without anyone noticing. A web scanner that continuously crawls every page, subdomain, and patient-facing property can detect unauthorized scripts, cookies without BAA coverage, and tracking pixels sending data to platforms that have no business receiving healthcare data. Every enforcement case in the reference record involved tracking that ran for years before anyone noticed. Continuous scanning is what prevents your organization from becoming the next case.

Evaluating Optimizely for Your Healthcare Properties

The answer to "Is Optimizely HIPAA compliant?" depends on which Optimizely product you are considering and how you plan to deploy it.

Optimizely Web Experimentation loads client-side JavaScript that observes visitor behavior on your healthcare pages and transmits data to Optimizely's servers. Without a BAA covering this data flow, this product creates the same category of risk that has generated $193 million in enforcement actions and settlements since 2023. Healthcare organizations should evaluate this product with extreme caution.

Optimizely Feature Experimentation operates server-side, giving you architectural control over what data reaches Optimizely. If you can configure it so that no PHI is transmitted, and if you can obtain appropriate contractual protections, the compliance posture is fundamentally different. However, "can be configured safely" is not the same as "is safe by default." The burden falls on your team to ensure the implementation is correct and remains correct over time.

Regardless of which product you evaluate, the broader question is whether your entire site is governed. A compliant experimentation tool sitting alongside unmonitored tracking pixels, third-party analytics scripts without BAAs, and abandoned marketing tags does not protect you. The organizations in every enforcement case had some compliant tools. They also had ungoverned ones. The ungoverned tools are what triggered the settlements.

Healthcare compliance is also evolving toward stronger consent requirements. State privacy laws continue to expand, patient expectations around data transparency are increasing, and regulators have signaled that consent management will be a central focus going forward. Building your experimentation and analytics infrastructure on consent-gated, server-side architecture now positions you for where the regulatory landscape is heading, not just where it is today.

Ours Privacy provides server-side analytics, web scanning, and consent-gated data architecture built for healthcare. If you are evaluating experimentation tools for patient-facing properties, start a conversation with our team.

Frequently Asked Questions

Does Optimizely sign a Business Associate Agreement for its Web Experimentation product?

Optimizely does not typically offer a BAA for its Web Experimentation (client-side) product. Without a BAA, Optimizely is not accepting HIPAA liability for data its JavaScript collects on your healthcare site. If you are evaluating Optimizely for healthcare use, ask explicitly whether a BAA is available for the specific product you plan to deploy, and review what data types that BAA covers.

Can Optimizely's server-side product be used in healthcare?

Optimizely Feature Experimentation (the server-side product) gives you control over what data leaves your infrastructure. Because experiment decisions happen on your server, you can architect the integration so no PHI reaches Optimizely. This makes it a more viable option for healthcare, but you still need appropriate contractual protections and careful implementation to ensure no health data is inadvertently transmitted.

What data does Optimizely Web Experimentation collect on healthcare pages?

Optimizely's client-side JavaScript observes page URLs, user interactions (clicks, form engagement, scroll behavior), experiment variant assignments, and conversion events. On healthcare pages, this can include URLs containing condition names, interactions with symptom checkers or appointment forms, and behavioral patterns on pages about specific health services. All of this data is transmitted to Optimizely's servers for experiment analysis.

How is Optimizely different from the tracking tools involved in healthcare settlements?

The enforcement cases involving Kaiser ($47.5M), Advocate Aurora ($12.25M), and others centered on client-side scripts transmitting healthcare page data to third-party servers without BAAs. Optimizely Web Experimentation follows the same architectural pattern: client-side JavaScript that collects behavioral data and sends it to Optimizely's infrastructure. The use case differs (experimentation vs. analytics or advertising), but the data flow structure and compliance gap are similar.

What should I do if Optimizely is already running on my healthcare website?

Start by identifying which Optimizely product is deployed and on which pages. If it is Web Experimentation running on patient-facing pages, assess what data has been flowing to Optimizely's servers and whether any of it could constitute PHI. Consult your compliance team about whether the historical data exposure requires further analysis. Then evaluate whether to migrate to a server-side experimentation approach or implement additional safeguards. Use a web scanner to check for Optimizely scripts and any other unmonitored third-party code across all your web properties.